Diabetes, sleep apnea, obesity—these are just a few of the health conditions doctors say might cause low testosterone levels, and should be treated individually before resorting to hormone therapies now associated with testosterone lawsuits.

NPR.org reported today on the causes of “Low T” levels and the importance of men taking the steps to manage them correctly before considering supplements similar to those now involved in Axiron, Testim and AndroGel-related claims. According to an endocrinologist and clinical director of the Mount Sinai Diabetes Center, men are urged to have their testosterone level measured by way of a simple blood test administered twice a day on two different days in order to confirm results. He added that obesity is a common cause of “Low T” levels because fat tissue can transform testosterone into estradiol, a hormone found in females.

Sleep apnea is another common cause of this condition, according to NPR.org, which goes on to recommend that men taking supplements similar to those involved in testosterone lawsuit litigation should be reevaluated every six months for blood pressure and red blood cell production.

At Least 50 Federal Claims Now Filed in Testosterone Lawsuit Litigation

Meanwhile, court records indicate that the number of claims filed over certain “Low T” medications is continuing to increase. A motion recently filed with the U.S. Judicial Panel on Multidistrict Litigation (JPML) asserts that some 50 testosterone lawsuits have been filed in federal jurisdictions throughout the U.S., warranting the need for a centralized proceeding. In a request from April 11th, plaintiffs say the consolidation of claims in the U.S. District Court, Eastern District of Louisiana would conserve the resources of the court and avoid duplicative discovery in allegations involving the risk for strokes, heart attacks and sudden cardiac death in men over the age of 65, and younger men with pre-existing heart disease.

The Panel is currently considering a similar request for a federal multidistrict litigation in the U.S. District Court, Northern District of Illinois by separate AndroGel lawsuit claimants.

On January 31, 2014, the U.S. Food and Drug Administration (FDA) announced its safety review of this “Low T” treatment and several others after the findings of new research tied use of the medications to serious heart problems.

Filing a Testosterone Lawsuit

Call our Firm to learn more about the risk for heart attacks, strokes and death that are allegedly associated with certain prescription testosterone treatment therapies. Contact us now at (877) 779-1414.

Published April 28, 2014 by